This information secures the diagnosis and classification as a basis for risk-stratified treatment using the international
prognostic scoring system (Table 3).
After an introductory discussion by author VJL, the panel specifically reviewed the treatment options for patients in the lower-, intermediate- and higher-risk groups, according to the International
Prognostic Scoring System (IPSS) categories LOW, intermediate-1 (INT-1) and HIGH (IPSS category HIGH, INT-2).
Approximately 77% of patients were aged 70 years or older and 84% were scored as intermediate-2 or high risk by IPSS, the International
Prognostic Scoring System. Baseline blast counts were between 11% and 29% in 51% of the patients.
Refinement of the international
prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).
During the evolution of APACHE III, the goal was to develop an improved method for estimating pretreatment risk of death, as well as a comprehensive and reliable
prognostic scoring system (Knaus, Draper, & Wagner, 1989)
As this tumor has great propensity for dissemination to sites other than the primary site with frequent involvement of lungs, vagina, brain and liver a thorough systemic evaluation of the patient should be carried out in all cases of choriocarcinoma and the patient should be scored according to WHO FIGO
prognostic scoring system to determine the choice of chemotherapy9.
To predict the time to first treatment (TTFT) in patients of early stages, we evaluated the prognostic role of conventional markers as well as cytogenetic abnormalities and combined them together in a new
prognostic scoring system, the CLL prognostic index (CLL-PI).
performed a retrospective analysis of 64 patients surgically treated for spinal metastases to devise a preoperative
prognostic scoring system, comprised of six parameters, to guide surgical intervention [19].
Future studies with large sample size will reveal the usefulness of this
prognostic scoring system.
Overall survival according to the revised international
prognostic scoring system.
Under the phase 2/3 clinical trial, imetelstat will be examined in transfusion dependent patients with International
Prognostic Scoring System Low or Intermediate-1 risk MDS that have relapsed after or are refractory to prior treatment with an erythropoiesis-stimulating agent.